Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.40)
# 3,576
Out of 5,090 analysts
70
Total ratings
43.9%
Success rate
-11.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $242.28 | +37.44% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.68 | +86.57% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.12 | +118.45% | 5 | Nov 5, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $51.31 | +26.68% | 12 | Aug 8, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $39.54 | +1.18% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $7.78 | +2.83% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $2.75 | +154.36% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $95.43 | +30.99% | 9 | Feb 26, 2025 |
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $242.28
Upside: +37.44%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.68
Upside: +86.57%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.12
Upside: +118.45%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $51.31
Upside: +26.68%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $39.54
Upside: +1.18%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $7.78
Upside: +2.83%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.75
Upside: +154.36%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $95.43
Upside: +30.99%